Autor/in Knecht, Rainald Bier, H 1 Hambek, M 1 Hauser, U 1 Hoffmann, T 1 Kiefer, J 1 Kovar, A 1 Müser, M 1 Ochler, M 1 Roller, M 1 Schnuerch, H G 1 Solbach, C 1 Stegmueller, M 1 Sterner-Kock, A 1 Wink, M 1 alle zeigenListe einklappen
Tumor necrosis factor alpha sensitizes low epidermal growth factor receptor (EGFR)-expressing carcinomas for anti-EGFR therapy. Hambek, M Solbach, C Schnuerch, H G Roller, M Stegmueller, M Sterner-Kock, A Kiefer, J 2001 - Forschungsinformationssystem des UKE
Clinical trial with escalating doses of the antiepidermal growth factor receptor humanized monoclonal antibody EMD 72 000 in patients with advanced squamous cell carcinoma of the larynx and hypopharynx. Bier, H Hoffmann, T Hauser, U Wink, M Ochler, M Kovar, A Müser, M 2001 - Forschungsinformationssystem des UKE